Trevena Inc (TRVN)
0.3699
-0.03
(-7.99%)
USD |
NASDAQ |
Apr 18, 16:00
0.35
-0.02
(-5.38%)
After-Hours: 20:00
Trevena SG&A Expense (Quarterly): 4.611M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.611M |
September 30, 2023 | 4.572M |
June 30, 2023 | 5.138M |
March 31, 2023 | 6.089M |
December 31, 2022 | 5.725M |
September 30, 2022 | 7.683M |
June 30, 2022 | 10.31M |
March 31, 2022 | 11.01M |
December 31, 2021 | 9.761M |
September 30, 2021 | 10.44M |
June 30, 2021 | 10.54M |
March 31, 2021 | 7.368M |
December 31, 2020 | 8.227M |
September 30, 2020 | 4.089M |
June 30, 2020 | 3.30M |
March 31, 2020 | 3.632M |
December 31, 2019 | 3.64M |
September 30, 2019 | 3.201M |
June 30, 2019 | 3.311M |
March 31, 2019 | 3.06M |
December 31, 2018 | 4.073M |
September 30, 2018 | 3.908M |
June 30, 2018 | 5.926M |
Date | Value |
---|---|
March 31, 2018 | 5.072M |
December 31, 2017 | 5.143M |
September 30, 2017 | 5.232M |
June 30, 2017 | 4.385M |
March 31, 2017 | 4.879M |
December 31, 2016 | 4.384M |
September 30, 2016 | 4.078M |
June 30, 2016 | 3.697M |
March 31, 2016 | 3.918M |
December 31, 2015 | 3.82M |
September 30, 2015 | 2.780M |
June 30, 2015 | 3.107M |
March 31, 2015 | 3.090M |
December 31, 2014 | 2.370M |
September 30, 2014 | 2.537M |
June 30, 2014 | 2.476M |
March 31, 2014 | 2.021M |
December 31, 2013 | 1.874M |
September 30, 2013 | 1.211M |
June 30, 2013 | 0.8713M |
March 31, 2013 | 0.7614M |
December 31, 2012 | 0.6429M |
September 30, 2012 | 0.8042M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
3.201M
Minimum
Sep 2019
11.01M
Maximum
Mar 2022
6.455M
Average
5.725M
Median
Dec 2022
SG&A Expense (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 2.609M |
Palatin Technologies Inc | 3.033M |
iBio Inc | 2.961M |
Theriva Biologics Inc | 2.021M |
Ampio Pharmaceuticals Inc | 0.973M |